Ignite Creation Date:
2024-05-06 @ 10:35 AM
Last Modification Date:
2024-10-26 @ 12:32 PM
Study NCT ID:
NCT03304080
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-06
First Post:
2017-10-03
Brief Title:
Anastrozole Palbociclib Trastuzumab and Pertuzumab in HR-positive HER2-positive Metastatic Breast
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Icahn School of Medicine at Mount Sinai
Organization Data
Organization:
Icahn School of Medicine at Mount Sinai
Class:
OTHER
Study ID:
GCO 17-0919
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Lead Sponsor Class:
OTHER
Responsible Party:
Amy Tiersten
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Icahn School of Medicine at Mount Sinai
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| NYU Langone Health | OTHER |
| Herbert Irving Comprehensive Cancer Center | OTHER |
| Weill Medical College of Cornell University | OTHER |